Search Results for “Quiz 2024 EMC D-PDM-DY-23: Dell PowerProtect Data Manager Deploy 2023 Exam Updated Vce Download 🌋 Copy URL ➥ www.pdfvce.com 🡄 open and search for ⇛ D-PDM-DY-23 ⇚ to download for free 🥇Latest D-PDM-DY-23 Test Testking” – Page 49

Disease activity only moderately correlates with quality of life impairment in patients with chronic spontaneous urticaria

172

Koti, I., Weller, K., Makris, M., Tiligada, E., Psaltopoulou, T., Papageorgiou, C., Baiardini, I., Panagiotakos, D., Braido, F., and Maurer, M.+: Disease activity only moderately correlates with quality of life impairment in patients with chronic spontaneous urticaria. Dermatology 2013: 226; 371-379. IF: 1.68

71	Altrichter, S., Boodstein, N., and Maurer, M.+: Matrix metalloproteinase-9: A novel biomarker for monitoring disease activity in patients with chronic urticaria? Allergy 2009: 64; 652-656. IF: 6.38

137.	Folkerts, J., Stadhouders, R., Redegeld, F. A., Tam, S. Y., Hendriks, R. W., Galli, S., and Maurer, M.+: Effect of dietary fiber and metabolites on mast cell activation and mast cell-associated diseases. Front. Immunol. 2018: 9; 1067. eCollection. IF: 4.72

297	Ertaş, R., Ozyurt, K., Atasoy, M., Hawro, T., and Maurer, M.+: The clinical response to omalizumab in chronic spontaneous urticaria patients is linked to and predicted by IgE levels and their change. Allergy 2018: 73; 705-712. IF: 6.77

100	Dölle, S., Hoser, D., Rasche, C., Loddenkemper, C., Maurer, M. Zuberbier, T., and Worm, M.+: Long-term reduction in local inflammation by a lipid raft molecule in atopic dermatitis. Allergy 2010: 65; 1158-1165. IF: 6.29

Impaired T-cell-dependent protection against Leishmania major infection in HIV-positive patients is associated with worsened disease outcome

207

Ngouateu, O. B., Weller, K., Bröhl, K., Kamtchouing, P., Same-Ekobo, A., Dondji, B. , Maurer, M., and Stebut, E.+: Impaired T cell-dependent protection against Leishmania major infection in HIV-positive patients is associated with worsened disease outcome. Exp. Dermatol. 2015: 24; 302-304. IF: 2.67

o.207

16.	Maurer, M.: Chronic urticaria. In: Zuberbier, T. Grattan, C., and Maurer, M., editors: Urticaria and Angioedema. Heidelberg: Springer, 2010

Innate immunity in atopic dermatitis

17.

Mrabet-Dahbi, S. and Maurer, M.: Innate immunity in atopic dermatitis. In: Shiohara T., Amagai, M., Homey, B., Nakanishi, K., Woodfolk, J. A., Bieber, T., Flohr, C., Schittek, B., Hayakawa, J., Yu, H.-S., Oranje, A. P., Schmid-Grendelmeier, P., and Akdis, C. A., editors: Current Problems in Dermatology „Atopic Dermatitis“. Basel: S. Karger Publishers, 2011

386.	Chen, Y.-D., Krause, K., Tu, P., Zhao, Z.⁺, and Maurer, M.⁺: Response of omalizumab in normocomplementemic urticarial vasculitis. J. Allergy Clin. Immunol. Pract. 2020: 8; 2114-2117. IF: 8.86

o.386

345	Krause, K., Sabat, R., Witte-Händel, E., Schulze, A., Puhl, V., Maurer, M., and Wolk, K.+: Association of CCL2 with systematic inflammation in Schnitzler syndrome. Br. J. Dermatol. 2019: 180; 859-868. IF: TBD (IF 2018: 6.71)

Results